TLR9 Immunotherapy for Peritoneal Carcinomatosis
NCT07658196
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Malignant Ascites
Colorectal Adenocarcinoma
Peritoneal (Metastatic) Cancer
Appendiceal Adenocarcinoma
Interventions
DRUG:
ACM-CpG
Sponsor
Brown University